Search Results - "Massimi, D."

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    P468 Switching from adalimumab originator to ABP 501 biosimilar: a multicentre North Italian study by Barberio, B, Melatti, P, Zingone, F, Bertani, L, Ferronato, A, GUBBIOTTI, A, Massimi, D, D’Incà, R, Savarino, E V

    Published in Journal of Crohn's and colitis (15-01-2020)
    “…Abstract Background In late 2018, adalimumab (ADA) biosimilars have been approved by the EMA with the same indications of the reference product (RP), that is…”
    Get full text
    Journal Article
  15. 15
  16. 16

    P843 Intestinal microbiota changes according to disease activity in patients with ulcerative colitis by Barberio, B, Bertazzo, E, Marinelli, C, Massimi, D, Ghisa, M, Gubbiotti, A, Casadei, C, Lorenzon, G, Zingone, F, D’Incà, R, Savarino, E V

    Published in Journal of Crohn's and colitis (15-01-2020)
    “…Abstract Background Intestinal dysbiosis has been consistently described in patients with inflammatory bowel disease (IBD), particularly about changes in gut…”
    Get full text
    Journal Article
  17. 17

    P438 Real-life effectiveness and safety of ABP501, an adalimumab biosimilar, in inflammatory bowel disease: a multicentre Italian study by Barberio, B, Zingone, F, Ferronato, A, Buda, A, Melatti, P, Gubbiotti, A, Massimi, D, Casadei, C, Cingolani, L, Savarino, E V

    Published in Journal of Crohn's and colitis (15-01-2020)
    “…Abstract Background Recently, various adalimumab (ADA) biosimilars have been approved by the EMA with the same indications of the reference product (Humira),…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures by Elia, Stefano, Massoud, Renato, Guggino, Gianluca, Cristino, Benedetto, Cortese, Claudio, De Massimi, Alessia Raffaella, Zenobi, Rossella

    “…Objective: Pleural effusion is a common diagnostic problem and a challenge to the thoracic surgeon. The analysis of serum and body fluids for tumor markers is…”
    Get full text
    Journal Article
  20. 20